Back to dashboard
Episode 252
DIP Episode 252 - Post Exposure Prophylaxis and The NBMEs
Infectious DiseaseMedium4 - HighHas Q&A
Step 1Step 2Step 3COMLEXMedicineUSMLEStep 1Step 2Step 3
Topic
Post-Exposure Prophylaxis (PEP); Hepatitis B; HIV PEP; Varicella Zoster Virus (VZV) prophylaxis; Rabies prophylaxis...
Key Takeaway
PEP involves administering vaccines, immune globulins, or antibiotics following exposure to an infectious agent, with protocols highly dependent on the specific pathogen, the patient's immune status, and the time elapsed since exposure.
Runtime: 23.6 min
Published: 2020-08-01
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: MICROBIOLOGY, SPECIAL TOPICS/RISK FACTORS
Episode Notes
Source / episode info
- Episode: 252
- Title: Divine Intervention Episode 252 – Post Exposure Prophylaxis and The NBM Es.
- Published: 2020-08-01
- Source: Episode page
One-liner
Episode 252 is a comprehensive review of post-exposure prophylaxis for multiple pathogens (HBV, HIV, VZV, Rabies, TB, Tetanus), emphasizing specific vaccine/immunoglobulin protocols, contraindications (e.g., live vaccines in immunocompromised patients), and critical timing guidelines required for board success.
High-yield summary
- Tetanus PEP: If unsure of vaccination history or >10 years since last dose, administer Tdap vaccine + Tetanus Immune Globulin (TIG). If <5 years, no action is needed regardless of wound severity.
- HBV Neonate Care: A newborn exposed to a mother with H BsAg positive status requires both the Hepatitis B vaccine and Hepatitis B immune globulin (HB Ig), administered in separate arms.
- TB Screening: For high-risk individuals (e.g., immunocompromised, recent travel) or those with TST > 5 mm, perform an IGRA; if positive, initiate latent TB regimen (INH + Pyridoxine/Vitamin B6).
- Rabies PEP: Requires both Rabies Immune Globulin (RIG) and the vaccine. RIG should be infiltrated directly around the wound site to neutralize local toxin.
- Live Vaccines Contraindications: Live attenuated vaccines (e.g., Varicella, MMR) are contraindicated in immunocompromised patients (e.g., HIV with CD4 < 200 cells/mm³), who must instead receive immune globulins or alternative therapies.
Learning objectives
- Differentiate the appropriate post-exposure prophylaxis regimens for HBV, HIV, VZV, and Rabies based on exposure risk and patient immune status.
- Apply critical thinking regarding vaccine administration guidelines (e.g., separate sites for HB Ig/vaccine; infiltration site for RIG).
- Recognize contraindications to live vaccines in immunocompromised patients and know the appropriate substitute immunoglobulins.
- Master the timing rules for Tetanus prophylaxis based on vaccination history (<5 years vs. >10 years or unknown).
- Understand the principles of TB screening (TST vs. IGRA) and the initiation of LTBI treatment with INH/Pyridoxine.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Hepatitis B PEP | H BsAg positive mother; Neonate | Vaccine + Immune Globulin (separate arms) | Remember to give both the vaccine and the immune globulin for neonates. |
| Tetanus PEP | Unknown history or >10 years since last dose | Tdap vaccine + TIG | The <5 year window is key; if recent, nothing is needed regardless of wound severity. |
| Rabies PEP | Deep/contaminated wound exposure | RIG infiltrated at the wound site | Infiltration maximizes local neutralization of the toxin. |
| TB Screening | High-risk patient (e.g., HIV, transplant) | IGRA preferred over TST | If positive, initiate INH prophylaxis and supplement with Pyridoxine (Vitamin B6). |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| HBV Neonate | Vaccine + Immune Globulin | Mother H BsAg positive; Newborn < 1 month old. | Must be given in separate, distinct injection sites to prevent immune globulin from neutralizing the vaccine. |
| Tetanus Timing | Unknown history or >10 years ago | Deep/dirty wound exposure. | Requires both Tdap and TIG. If recent (<5 years), no prophylaxis is needed. |
| TB Screening | Immunocompromised patient; High suspicion of exposure | IGRA (Interferon Gamma Release Assay) | Preferred test over TST in high-risk groups due to cross-reactivity issues. Positive result requires INH + Pyridoxine. |
| Rabies PEP | Animal bite/exposure | RIG infiltrated at the wound site; Vaccine series given later. | The local administration of RIG is crucial for neutralizing the toxin immediately upon entry. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A healthcare worker sustains a needlestick injury from blood positive for H BsAg, and the patient is known to be non-immune. | Hepatitis B PEP | Requires both Hepatitis B vaccine AND Hepatitis B immune globulin (HB Ig), administered in separate sites. |
| A child with suspected varicella develops a rash after exposure from an immunocompromised source; the child is <1 year old. | Varicella Zoster Immune Globulin (VZIG) | Live vaccines are contraindicated in infants and severely immunocompromised patients. VZIG provides immediate passive immunity. |
| A patient presents with a deep, contaminated wound following animal bite exposure, and their vaccination history is unknown. | Tetanus PEP | Unknown or lapsed history requires both the Tetanus vaccine (Tdap) AND Tetanus Immune Globulin (TIG). |
| An immunocompromised individual has an elevated TST reading of 10 mm following potential exposure to a patient with active TB. | Latent Tuberculosis Infection (LTBI) | High-risk patients or positive TST/IGRA require prophylactic treatment, typically Isoniazid (INH) for 9 months. |
| A person is exposed to rabies and requires immediate post-exposure management. | Rabies PEP | Requires both Rabies Immune Globulin (RIG) infiltrated at the wound site AND the Rabies vaccine series. |
| The patient has a history of HIV infection with a CD4 count < 200 cells/mm³ and is exposed to VZV. | Varicella Zoster Immune Globulin (VZIG) | Immunocompromise contraindicates live vaccines; passive immunity via VZIG is necessary. |
Differential diagnosis / distinguishing features
TB Screening Methods
| Key Features | Distinguishing Findings | Next Step |
| Tuberculin Skin Test (TST) | Measures delayed hypersensitivity reaction to PPD protein. | Used for general screening; interpretation is complex due to cross-reactivity (e.g., BCG vaccine). |
| Interferon Gamma Release Assay (IGRA) | Measures T-cell response to specific Mycobacterium tuberculosis antigens. | Preferred test in immunocompromised patients or those with known risk factors, as it avoids cross-reactivity issues seen with TST. |
Management pearls
- HBV Neonate: Always remember the "two shots" rule: Vaccine + Immune Globulin (separate arms).
- Tetanus Wound Care: The decision tree is based on time elapsed since last dose, not wound severity (if <5 years).
- Rabies RIG Site: When administering Rabies Immune Globulin, always infiltrate it directly into the wound site to maximize local neutralization of the toxin.
- TB Prophylaxis: If initiating INH for LTBI, always supplement with Pyridoxine (Vitamin B6) to prevent peripheral neuropathy.
Don't miss
🚨
N95 Mask Use: For TB exposure, a surgical mask is insufficient; an N95 or P100 respirator is required protection.
🚨
Live Vaccine Contraindications: Never give live vaccines (e.g., Varicella vaccine) to severely immunocompromised patients (e.g., HIV with CD4 < 200 cells/mm³). Use immune globulins instead.
🚨
HBV PEP Principle: The goal of prophylaxis is always to provide immediate passive immunity (via Ig) and long-term active immunity (via Vaccine).
Integration & clinical reasoning
- Immunology Integration: Understanding the difference between passive immunity (IgG from immune globulin, providing immediate protection) and active immunity (vaccine, requiring time for B/T cell response) is central to all PEP protocols.
- Infectious Disease Epidemiology: Recognizing that prophylaxis guidelines are constantly updated based on vaccine availability, drug resistance patterns, and public health recommendations (e.g., changes in HIV regimens).
- Vaccinology Principles: Knowing the specific contraindications for live vaccines across various patient populations (age, pregnancy status, immune deficiency).
Concept connections / cross-references
- For detailed information on general infectious disease transmission routes and prevention: [Episode 10]
- For comprehensive review of vaccine schedules and pediatric immunization guidelines: [Episode 37]
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Hepatitis B | Neonatal prophylaxis | H BsAg positive mother -> Vaccine + HB Ig | Failure to administer both components leaves the neonate unprotected. |
| Tetanus | Unknown history or >10 years since last dose | Tdap vaccine + TIG | This combination provides immediate (TIG) and long-term (Tdap) protection against Clostridium tetani toxin. |
| Rabies | Wound exposure | RIG infiltration at wound site | Local administration of immune globulin is critical for neutralizing the neurotoxin before it reaches the CNS. |
| TB Infection | Immunocompromised status (e.g., HIV) | IGRA testing preferred over TST | IGRA avoids false positives/negatives caused by cross-reactivity with other infections or prior BCG vaccination. |
Key terms glossary
| Term | Definition | Context | Example |
| Post-Exposure Prophylaxis (PEP) | Preventive treatment given after potential exposure to an infectious agent. | Used for HBV, HIV, Rabies, etc. | Giving HB Ig and vaccine after a needlestick injury from an infected source. |
| Immune Globulin | Preformed antibodies (passive immunity) administered directly into the patient. | Used when immediate protection is needed (e.g., RIG, HB Ig). | Administering VZIG to an immunocompromised child exposed to varicella. |
| Tdap/TIG | Tdap vaccine combined with Tetanus Immune Globulin. | Standard prophylaxis for tetanus in high-risk patients. | Given when a wound is dirty and the patient's history is unknown or >10 years ago. |
| Pyridoxine (Vitamin B6) | A necessary cofactor for certain metabolic pathways; prevents neuropathy. | Supplemented with INH therapy for LTBI. | Prevents peripheral neuropathy associated with long-term Isoniazid use. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| PEP Protocols | Create flowcharts/decision trees based on the pathogen and patient status (e.g., Tetanus, HBV). | High | Review guidelines for specific pathogens (HBV, HIV, VZV) in detail. |
| Vaccine Contraindications | Memorize which live vaccines are contraindicated in which immune-compromised states. | Medium-High | Focus on the "Live Vaccine Rule": Immunocompromised = Use Immune Globulin/Alternative. |
| TB Management | Understand the difference between TST and IGRA, and the specific drug regimen for LTBI. | High | Practice interpreting lab results (e.g., 5mm threshold for TST). |
Question pattern recognition
- Pattern: Neonate exposed to H BsAg+ mother -> Requires both HBV vaccine AND HB Ig in separate arms.
- Pattern: Unknown/Lapsed Tetanus history + Dirty wound -> Administer Tdap vaccine and TIG.
- Pattern: Immunocompromised patient (CD4 < 200) exposed to VZV -> Use Varicella Zoster Immune Globulin (VZIG), as live vaccines are contraindicated.
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Confusing HBV/VZV prophylaxis. Do not confuse the required immunoglobulins (HB Ig for HBV, VZIG for VZV).
🚫
Mistake 2: Tetanus timing rule reversal. Remember that if the patient is <5 years since their last dose, nothing is needed, even with a dirty wound.
🚫
Mistake 3: TB mask type. Always remember N95/P100 for airborne pathogens like TB; surgical masks are insufficient.
Common traps
⚠️
Trap 1 (Tetanus): The most common trap is assuming that wound contamination dictates the need for TIG, when in fact, the time since last vaccine is the primary determinant of whether prophylaxis is needed at all.
⚠️
Trap 2 (HBV Neonate): Students often forget to administer both components (vaccine AND immune globulin) or fail to remember that they must be given in separate injection sites.
⚠️
Trap 3 (TB Screening): Assuming TST is always superior; IGRA is the preferred test for high-risk groups due to cross-reactivity concerns.
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics, Autonomics & COMAT Shelf Clinical Pearls:
- Foregut Viscerosomatic Reflexes (T5–T9): Upper gastrointestinal structures (stomach, liver, gallbladder, spleen, and pancreas) receive sympathetic innervation from T5–T9 through the greater splanchnic nerve synapsing at the Celiac ganglion. Parasympathetic tone is supplied by the Vagus nerve (CN X). Palpate for acute tissue texture changes and right-sided paraspinal erythema at T5–T9 in acute cholecystitis or hepatitis.
- Chapman Reflex Points: Stomach (acidity) anterior point is located in the left 5th intercostal space mid-clavicular line; liver and gallbladder points are in the right 6th intercostal space. The pancreas anterior point lies in the right 7th intercostal space.
- Lymphatic Drainage & Mesenteric Lift: Celiac collateral ganglion inhibition (gentle posterior pressure over the epigastrium 1 inch below the xiphoid) down-regulates painful sympathetic spasm. In liver disease or portal hypertension, releasing the thoracic inlet and doming the abdominal diaphragm promotes venous return through the inferior vena cava and thoracic duct.